Evaluating Kylo-11 for Long-Acting Lipoprotein(a) Suppression

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals by Cleveland Clinic Heart & Vascular Institute

Steven Nissen, MD, and Ashish Sarraju, MD, discuss early clinical data on Kylo-11, a novel therapy that produced substantial reductions in lipoprotein(a) for up to one year after a single injection. Lowering lipoprotein(...View more